Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.01 CAD | 0.00% | +9.85% | +173.64% |
05:31pm | Cardiol Therapeutics Says Phase II ARCHER Trial Presented at World Congress on Acute Heart Failure | MT |
04-22 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
- Stock Market
- Equities
- CRDL Stock
- News Cardiol Therapeutics Inc.
- MarketScreener Editorial Features